Multiple sclerosis may quietly damage the brain for years before symptoms appear, and scientists can now see it coming.
Multiple sclerosis is a disease in which the immune system erroneously attacks a protective insulation that surrounds neurons ...
A brain protein called ANO2 has emerged as a new piece of the puzzle linking Epstein-Barr virus (EBV) infections and MS ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Multiple sclerosis is a chronic disease where your immune system starts attacking your brain and spinal ...
If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to attack its own nervous system. This mechanism can accelerate the progression of ...
Multiple sclerosis (MS) is a serious neurological disease that usually causes permanent disability. Approximately 2.9 million people are affected worldwide, 240,000 in Germany alone. The exact cause ...
Multiple sclerosis (MS) is a serious neurological disease that usually causes permanent disability. Approximately 2.9 million people are affected worldwide, 240,000 in Germany alone. The exact cause ...
An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study. The drug appears ...
Scientists from Oregon Health & Science University (OHSU) and the University of Edinburgh have discovered that a little-understood junction that connects neurons to oligodendrocyte precursor cells ...
If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to attack its own nervous system. This mechanism can accelerate the progression of ...
Pediatric multiple sclerosis researchers at UB are working to define and better understand previously unappreciated and uncommon types of childhood demyelinating disorders, including MS, to improve ...
Researchers headed by a team at Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health (CAMH) reported promising data from preclinical in vivo studies evaluating a ...